Advanced Search
Displaying 21-30 on page 3 of 82. Per Page  

Articles / Online

  • Growth and Invasion of 3D Spheroid Tumor of HeLa and CasKi Cervical Cancer Cells
  • Abstract Spheroids are generally self-assembled cells with the ability to generate their extracellular matrix, including the complex cell-matrix and the cell-cell interactions that resemble the functional characteristics of the corresponding tissue in vivo. The study aimed to develop a three-dimensional (3D) spheroid system for the cervical cancer cell lines, HeLa (HPV18), CaSki (HPV16), SiHa (HPV16), C33A (non-HPV), HT3 (non-HPV) as well as to identify its biological activity in the extracellular form. For the formation of the cervical cancer spheroids, the liquid overlay approach was applied, followed by embedding to the bovine collagen I matrix. Spheroid formation using the liquid overlay approach…
  • More
  •   Views:427       Downloads:479        Download PDF
  • Tolerance and Efficacy of Regorafenib according to UGT Pharmacogenetical Status in the Treatment of Metastatic Refractory Colorectal Cancer
  • Abstract Introduction: Regorafenib is a multi tyrosin-kinase inhibitor prescribed in metastatic refractory colorectal cancer treatment. Its toxicity is significant but inconstant. The metabolism of regorafenib includes oxydation via cytochrome P3A4, then glucuroconjugation. A pharmacogenetical approach of mutational status of Uridine-Diphospho-Glucuronosyltransfersase (UDP-glucuronosyl-transferase, UGT) could be a strategy to optimise the use of regorafenib. Patients and Method: This is a restrospective, unicentric study. All adult patients treated with regorafenib for a metastatic colorectal cancer in our center between 2013 and 2017 were analysed. UGT1A1 polypmorphism was previously researched in the laboratory after written informed consent. Results: Thirty-five patients received regorafenib during the study…
  • More
  •   Views:447       Downloads:350        Download PDF
  • MicroRNA in HCC: Biomarkers and Therapeutic Targets
  • Abstract Hepatocellular carcinoma (HCC) is a malignant tumor with high morbidity and mortality. At present, diagnostic methods such as imaging observation, serum testing and tissue biopsy, as well as treatment methods such as surgical resection, radiotherapy, and chemotherapy have certain limitations in clinical interventions for HCC due to the complex pathogenesis and drug resistance of liver cancer, which seriously affect the survival and prognosis of patients. As a large-scale cytokine, microRNA (miRNA) plays an important role in regulating various life activities of cells. Extensive evidence proved that certain miRNAs are specifically expressed in the tissues and blood of HCC patients, and…
  • More
  •   Views:499       Downloads:387        Download PDF
  • Accès au premier traitement : apport d’un centre de prise en charge rapide
    Access to First Treatment: Contribution of a Quick Care Centre
  • Abstract For a patient suffering from breast cancer, access to the initial treatment includes several steps like confirmation of an anatomopathological diagnosis, proposition and establishment of an individualized treatment plan, pretreatment assessments, and access to the technical platform. The accumulated duration of these intervals plays a role in the prognosis in the early stages of the disease. In addition, it is important to manage all the uncertainties, both diagnostic and prognostic, which will inevitably upset the patient’s psychological balance. Supported by literature, recommendations and more than 20 years of experience in a multidisciplinary centre, the authors propose the organization of an…
  • More
  •   Views:266       Downloads:243        Download PDF
  • Épidémiologie des tumeurs neuroendocrines intestinales *
    Epidemiology of Neuroendrocine Intestinal Tumours
  • Abstract Little is known about the epidemiology of digestive neuroendocrine tumours (NETs). NETs remain a rare cancer, representing 1% of all digestive cancers. In France, incidence rates are estimated to around 1.1/100,000 inhabitants in males and 0.9/100,000 in females. The incidence rates got increased over time, with probably more than 1,000 new cases per year in France. Because of their relatively good prognosis, NETs are the second more prevalent digestive cancer after colorectal cancer. Most digestive NETs are well-differentiated (WDNETs); poorly differentiated neuroendocrine carcinomas (PDNEC) account for less than 20% of the cases in most of the series. Among bowel-NETs, the…
  • More
  •   Views:279       Downloads:299        Download PDF
  • Diagnostic des phéochromocytomes et paragangliomes *
    Diagnosis of Pheochromocytomas and Paragangliomas
  • Abstract Pheochromocytoma and paraganglioma are tumors leading to increased morbidity and mortality. Over the last 20 years, several major advances allowed a better characterization of these tumors, either from an imaging or from a genetic viewpoint. This is especially the case for the hereditary characteristics of these tumors, as roughly 20 new genes have been identified. This is why the initial steps of the management of a pheochromocytoma and/or a paraganglioma now require a dedicated tertiary referral center. The aim of this review is to depict the diagnostic steps of these tumors, so as to allow the clinician to determine the…
  • More
  •   Views:265       Downloads:362        Download PDF
Displaying 21-30 on page 3 of 82. Per Page